[ Cardior Pharmaceuticals raises $16.31M in Series A ]
Cardior Pharmaceuticals has raised $16.31 million in Series A funding led by Bristol-Myers Squibb, Life Sciences Partners, High-Tech Gruenderfonds and BioMedPartners.
Founded in 2016, Cardior Pharmaceuticals focuses on developing non-coding Ribonucleic acid-based therapeutics for the treatment and prevention of heart diseases.
The company will use the new financing to continue to advance its therapeutics.
|Founder / CEO||Claudia Ulbrich|
|Life Sciences Partners|